Pulmonary innate immune remodeling in Pneumocystis pneumonia with adaptive immunodeficiency.
- 1Medical Research Center, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
- 2Laboratory for Clinical Medicine, Capital Medical University, Beijing 100020, China.
- 3Department of Respiratory and Critical Care Medicine, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing 100020, China.
Abstract
Background
Pneumocystis pneumonia (PCP) is a severe fungal infection that predominantly affects individuals with compromised immune systems, specifically those with adaptive immunodeficiency. The mechanisms governing the remodeling of the innate immune system in the context of PCP, particularly in the presence of complete adaptive immunodeficiency, remain insufficiently elucidated. Here, using single-cell RNA sequencing (scRNA-seq) in a murine PCP model, we reveal how innate immune responses are remodeled in the absence of adaptive immunity, providing new mechanistic insights into PCP pathogenesis and a foundation for targeted therapy.Methods
An experimental model of PCP was established using male CB-17 SCID mice with adaptive immunodeficiency. Mice were weight-matched into six pairs and randomly divided into a PCP group and a control (CON) group (n = 6 per group) using a computer-generated random sequence; PCP mice received an intranasal instillation of 1 × 10⁶ cysts in 100 μL sterile phosphate-buffered saline (PBS) under isoflurane anesthesia, whereas CON mice received an equal volume of sterile PBS alone. Lung tissues were collected for scRNA-seq to profile pulmonary innate immune cells. Bioinformatic analyses were employed to characterize several subsets of monocyte-derived macrophages, and immunofluorescence and quantitative reverse transcription PCR were used to validate these findings.Results
scRNA-seq indicated an expansion of Ccr2 ⁺ monocyte-derived Nckap5 ⁺ macrophages in PCP mice, which was associated with anti-inflammatory features and activation of pro-proliferative pathways. Inhibition of the MAPK pathway using Adezmapimod effectively reversed the induction of Nckap5 (4.463 ± 0.125 vs. 0.991 ± 0.052, P < 0.001) and the expression of anti-inflammatory cytokines, including Il10 (44.090 ± 1.246 vs. 4.131 ± 0.151, P < 0.001), Arg1 (2.455 ± 0.135 vs. 0.918 ± 0.018, P < 0.001) and Tgf β (1.147 ± 0.043 vs. 0.994 ± 0.031, P < 0.01).Conclusion
This study advances understanding of PCP pathogenesis and identifies Nckap5 ⁺ macrophages as a potential therapeutic target for patients with compromised immune systems.
Related
- Pneumocystis Jirovecii Pneumonia Associated with Prolonged CD4-positive T-cell Depletion after Bendamustine-Rituximab Therapy: A Case Report
- Added Value of Next-Generation Sequencing for Multilocus Sequence Typing Analysis of a Pneumocystis jirovecii Pneumonia Outbreak1
- Very Late-Onset Cytomegalovirus Disease With Pneumocystis jirovecii Pneumonia Coinfection in a Renal Transplant Recipient: A Case Report and Narrative Review of Published Cases.
- Efficacy and safety of adjuvant glucocorticoid therapy for Pneumocystis pneumonia (PCP) in patients positive for HIV: a systematic review and meta-analysis
- Pneumocystis jirovecii Pneumonia in an Adolescent With Acute Lymphoblastic Leukemia Due to Non-adherence to Prophylaxis: A Case Report.
BibTeX
@article{gu2026pulmonary,
title = {{Pulmonary innate immune remodeling in Pneumocystis pneumonia with adaptive immunodeficiency.}},
author = {Lin Gu and Wan Peng and Hanyujie Kang and Yuling Xu and Jieqiong Li and Zhaohui Tong and Nan Song},
journal = {Infectious diseases \& immunity},
year = {2026},
month = jun,
doi = {10.1097/id9.0000000000000216},
url = {https://europepmc.org/article/MED/42904279},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Pulmonary innate immune remodeling in Pneumocystis pneumonia with adaptive immunodeficiency.
AU - Lin Gu
AU - Wan Peng
AU - Hanyujie Kang
AU - Yuling Xu
AU - Jieqiong Li
AU - Zhaohui Tong
AU - Nan Song
PY - 2026
DA - 2026/06/09
JO - Infectious diseases & immunity
DO - 10.1097/id9.0000000000000216
UR - https://europepmc.org/article/MED/42904279
AB - Background Pneumocystis pneumonia (PCP) is a severe fungal infection that predominantly affects individuals with compromised immune systems, specifically those with adaptive immunodeficiency. The mechanisms governing the remodeling of the innate immune system in the context of PCP, particularly in the presence of complete adaptive immunodeficiency, remain insufficiently elucidated. Here, using single-cell RNA sequencing (scRNA-seq) in a murine PCP model, we reveal how innate immune responses are remodeled in the absence of adaptive immunity, providing new mechanistic insights into PCP pathogenesis and a foundation for targeted therapy.Methods An experimental model of PCP was established using male CB-17 SCID mice with adaptive immunodeficiency. Mice were weight-matched into six pairs and randomly divided into a PCP group and a control (CON) group (n = 6 per group) using a computer-generated random sequence; PCP mice received an intranasal instillation of 1 × 10⁶ cysts in 100 μL sterile phosphate-buffered saline (PBS) under isoflurane anesthesia, whereas CON mice received an equal volume of sterile PBS alone. Lung tissues were collected for scRNA-seq to profile pulmonary innate immune cells. Bioinformatic analyses were employed to characterize several subsets of monocyte-derived macrophages, and immunofluorescence and quantitative reverse transcription PCR were used to validate these findings.Results scRNA-seq indicated an expansion of Ccr2 ⁺ monocyte-derived Nckap5 ⁺ macrophages in PCP mice, which was associated with anti-inflammatory features and activation of pro-proliferative pathways. Inhibition of the MAPK pathway using Adezmapimod effectively reversed the induction of Nckap5 (4.463 ± 0.125 vs. 0.991 ± 0.052, P < 0.001) and the expression of anti-inflammatory cytokines, including Il10 (44.090 ± 1.246 vs. 4.131 ± 0.151, P < 0.001), Arg1 (2.455 ± 0.135 vs. 0.918 ± 0.018, P < 0.001) and Tgf β (1.147 ± 0.043 vs. 0.994 ± 0.031, P < 0.01).Conclusion This study advances understanding of PCP pathogenesis and identifies Nckap5 ⁺ macrophages as a potential therapeutic target for patients with compromised immune systems.
SN - 2096-9511
SN - 2693-8839
ER -